2006 Honda Element Ex-p on 2040-cars

Auto blog

10 automakers shack up in Detroit hotel to talk Takata airbags

Since Takata has decided not to take the lead concerning potential issues with its airbag inflators, the automakers have. Perhaps that's unsurprising, since it's the automakers, not Takata, that will take a beating on the dealership floor if consumers decide its models are a health hazards. The Detroit News reports that Toyota, Honda, General Motors, Ford, Chrysler, Mazda, BMW, Nissan, Mitsubishi and Subaru met in a hotel conference room near the Detroit Metropolitan Airport last week to sort out a way to understand the technical issues involved. So far, faulty airbag inflators have been ruled the cause of five deaths and 50 injuries around the world, but neither Takata nor investigators understands exactly why the inflators are malfunctioning. The National Highway Traffic Safety Administration recently asked Takata to issue a national recall, Takata declined, citing a minuscule failure rate and the fact that it's still investigating the issue. Toyota and Honda then made an industry-wide appeal for "a coordinated, comprehensive testing program" that would pinpoint the problem inflators and get them replaced, and that's what the Detroit meeting was about. Numerous issues, however, will make this a long row to hoe: simply getting the parts to replace the nearly 20 million inflators in cars recalled around the world so far - even working with other suppliers - will take a years, but more importantly, no one knows if the replacement inflators currently being installed will suffer the same issue. Answers will hopefully come quickly with Takata, the ten automakers and NHTSA all independently investigating the problem.

Honda Fit, Vezel Hybrids recalled in Japan; US vehicles not affected

Honda has announced a good-sized recall of two popular Japanese-market hybrids: the Fit Hybrid and the Vezel Hybrid are both headed back into the garage. The problem this time around lies in the software program that controls the 7-speed dual clutch transmission (DCT) that could "cause a delay in the ability to begin driving or the inability to move at all." In total, 81,353 units are affected (70,929 Fit Hybrids and 10,424 Vezel Hybrids) and all were made in Japan between July 2013 and February 2014. There were two previous recalls for the new Fit Hybrid's DCT, and you can find the details of them below. Jessica Fini, assistant manager of PR for Honda North America, told AutoblogGreen that this recall will not have any impact on US Honda vehicles. For one thing, the US Fit has a continuously variable transmission (CVT) instead of a DCT, so the upcoming launch of the new Fit here (the US doesn't get the Fit Hybrid) will not be delayed. Honda's upcoming small SUV in the US (based on the Vezel, but will arrive with a different name) isn't going to launch here until the end of the year, so there is time to fix any problems before launch. She also said that the Acura RLX, despite being a DCT, does not use the same transmission as the Fit Hybrid does, since the Fit transmission is specific to the one-motor hybrid system and the RLX uses three electric motors. Recall of All-New Fit Hybrid and Vezel Hybrid ref. # C14-009 TOKYO -- February 10, 2014 – Honda Motor Co., Ltd. today announced a voluntary recall of the all-new Fit Hybrid and Vezel Hybrid produced in Japan from July 2013 through February 2014 due to a problem with the software program controlling the 7-speed dual clutch transmission (DCT) which could cause a delay in the ability to begin driving or the inability to move at all. Honda today notified the Ministry of Land, Infrastructure, Transport and Tourism of the recall with a total recall population of 81,353 units. Honda conducted two recalls in October and December 2013 due to a defect with the software program controlling the 7-speed DCT which could have caused a delay in the ability to drive the vehicle or the inability to drive. This will be the third recall related to the defect of the 7-speed DCT.

Honda Walking Assist Device begins US testing at Rehabilitation Institute of Chicago

For years, we've been wondering what implications Honda's Asimo robot could have in the real world, and now we're starting to get a sense of that. Honda announced that it will begin its first US clinical studies of the Walking Assist Device at the Rehabilitation Institute of Chicago in an effort to provided improved mobility for people who have suffered a stroke. While the automotive tie-in here is pretty weak, this is the first time we've heard about this device since it was unveiled back in 2008.
Weighing in at six pounds, Honda's device is fitted to the waist and legs of patients to make it easier to walk, and the 22.2-volt lithium-ion battery provides enough electricity for more than an hour of operation. According to Honda's press release, which is posted below, up to 80 percent of the almost 800,000 stroke victims each year (in the US alone) are afflicted with limited mobility, so a medical aid like this could have a big impact in the real world.